Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic ... and safety of tezepelumab in ...

particularly if medications are not giving you enough relief for your chronic nasal congestion, says Dr. Roditi. You’re ...

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

Researchers emphasized the potential of Tezspire to offer a new treatment option that addresses the multiple inflammatory ...

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...